Skip to main content
. 2020 Jul 7;15(7):e0235611. doi: 10.1371/journal.pone.0235611

Fig 1. cfDNA concentration in patients with lung cancer or benign pulmonary disease and in healthy individuals.

Fig 1

(A) Comparison of cfDNA concentration among the three participant groups. (B) Comparison of cfDNA concentration by pathological stage of lung cancer. (C) Comparison of cfDNA concentration in patients with lung cancer according to presence or absence of distant metastasis.